Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency

Journal of Clinical Immunology

Volumn 30, Issue 2, 2010, Pages 314-320

  Rohr, Jan ^a   Pannicke, Ulrich ^b   Döring, Michaela ^c   Schmitt Graeff, Annette ^a   Wiech, Elisabeth ^a   Busch, Andreas ^a   Speckmann, Carsten ^a   Müller, Ingo ^c   Lang, Peter ^c   Handgretinger, Rupert ^c   Fisch, Paul ^a   Schwarz, Klaus ^b   Ehl, Stephan ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Artemis; Inflammatory bowel disease; Lymphopenia; Primary immunodeficiency

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; SALAZOSULFAPYRIDINE; STEROID; T LYMPHOCYTE RECEPTOR; TACROLIMUS;

ARTEMIS DEFICIENCY; ARTEMIS GENE; ARTICLE; B LYMPHOCYTE; CASE REPORT; CHILD; DISEASE COURSE; ENTERITIS; FEMALE; GASTROINTESTINAL CANDIDIASIS; GENE; GENETIC ANALYSIS; GENETIC RECOMBINATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; LYMPHOCYTOPENIA; MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE; THRUSH; UPPER RESPIRATORY TRACT INFECTION;

CELL LINE; CHILD; CLONING, MOLECULAR; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, T-CELL RECEPTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOPHENOTYPING; INFLAMMATORY BOWEL DISEASES; LYMPHOPENIA; LYMPHOPOIESIS; MUTATION; NUCLEAR PROTEINS; TRANSFECTION; ULCER;

EID: 77953544834     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9349-x     Document Type: Article

References (21)

1. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361: 2033-2045
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434
3. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 1993;5:1461-1471
4. Powrie F, Correa-Oliveira R, Mauze S, Coffman RL. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med. 1994;179:589-600.
5. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699
6. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274
7. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20-21
8. Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol. 2007;120:744-50. quiz 751-752
9. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 1993;75:274-282
10. Enders A, Fisch P, Schwarz K, Duffner U, Pannicke U, Nikolopoulos E, et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol. 2006;176:5060-5068
11. Pannicke U, Ma Y, Hopfner KP, Niewolik D, Lieber MR, Schwarz K. Functional and biochemical dissection of the structure-specific nuclease ARTEMIS. EMBO J. 2004;23:1987-1997
12. Moshous D, Pannetier C, Chasseval Rd R, Deist Fl F, Cavazzana-Calvo M, Romana S, et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest. 2003;111:381-387
13. de Villartay JP, Lim A, Al-Mousa H, Dupont S, Déchanet-Merville J, Coumau-Gatbois E, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115:3291-3299
14. Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, Kühr J, et al. A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest. 2005;115:3140-3148
15. Buck D, et al. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur J Immunol. 2006;36(1):224-235
16. Kumaki S, et al. Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency. Blood. 2001;98(5):1464-1468
17. Pasic S, et al. Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings. Acta Paediatr. 2009;98(6):1062-1064
18. Karaca NE, et al. Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID. Clin Exp Med. 2009;9:339-342
19. Ege M, Ma Y, Manfras B, Kalwak K, Lu H, Lieber MR, et al. Omenn syndrome due to ARTEMIS mutations. Blood. 2005;105:4179-4186
20. Peake J, Waugh A, Le Deist F, Priestley A, Rieux-Laucat F, Foray N, et al. Combined immunodeficiency associated with increased apoptosis of lymphocytes and radiosensitivity fibroblasts. Cancer Res. 1999;59:3454-3460
21. Villa A, Marrella V, Rucci F, Notarangelo LD. Genetically determined lymphopenia and autoimmune manifestations. Curr Opin Immunol. 2008;20:318-324